Build with KISHO Sign In Sign Up

Kisho

argenx BV — Rare Disease Pipeline | Kisho | Kisho

argenx BV

Other

6

Orphan Designations

0

FDA Approvals

15

Rare Diseases

0

News Articles

Disease	Drug(s)	Designation	Approved
adult neuronal ceroid lipofuscinosis	Vyvgart Hytrulo	Orphan Designation	-
adult pleomorphic rhabdomyosarcoma	Vyvgart Hytrulo	Orphan Designation	-
adult-onset non-insulinoma persistent hyperinsulinemic hypoglycemia	Vyvgart Hytrulo	Orphan Designation	-
adult-onset proximal spinal muscular atrophy, autosomal dominant	Vyvgart Hytrulo	Orphan Designation	-
chronic inflammatory demyelinating polyradiculoneuropathy	Vyvgart Hytrulo	Orphan Designation	-
congenital myasthenic syndrome	a fully humanized immunoglobulin gamma 1 (IgG1) agonistic monoclonal antibody (mAb) that specifically targets and activates MuSK	Orphan Designation	-
congenital myasthenic syndrome 3A	Vyvgart HytruloVyvgart	Orphan Designation	-
congenital myasthenic syndrome 4C	Vyvgart HytruloVyvgart	Orphan Designation	-
congenital myasthenic syndrome 5	Vyvgart HytruloVyvgart	Orphan Designation	-
congenital myasthenic syndrome 6	Vyvgart HytruloVyvgart	Orphan Designation	-
idiopathic inflammatory myopathy	efgartigimod coformulated with recombinant human hyaluronidase PH20	Orphan Designation	-
multifocal motor neuropathy	empasiprubart	Orphan Designation	-
myasthenia gravis	Vyvgart HytruloVyvgart	Orphan Designation	-
myasthenic syndrome, congenital, 1B, fast-channel	Vyvgart HytruloVyvgart	Orphan Designation	-
primary adult heart tumor	Vyvgart Hytrulo	Orphan Designation	-

← Back to Companies